BIOSECURE Act

The exception for existing contracts in subsection (c)(3) was narrowed: 'currently negotiated contract option years' was changed to 'previously negotiated contract options,' which likely limits the scope of grandfathered contracts that are exempt from the prohibition.

The definition of 'appropriate congressional committees' now includes the Senate Select Committee on Intelligence and the House Permanent Select Committee on Intelligence, expanding which committees receive notifications and reports under the Act.

The five-year transition period for newly designated biotechnology companies of concern (subsection f(2)(B)) now runs from 'the issuance of the regulation in subsection (h) that identifies' the company, rather than simply from 'the identification' of the company. This ties the clock to a formal regulatory action.

The National Cyber Director was added to the list of officials who coordinate with OMB on guidance (subsection f(3)), list updates (subsection f)(4)), and the national security risk assessment (subsection g)(1)).

The definition of 'contract' in subsection (k)(3) now includes an exception: 'Except as the term is used under subsection (b)(2) and subsection (c)(3),' meaning those subsections use a broader or different understanding of contract than the Federal Acquisition Regulation-based definition.